The company utilizes third-party manufacturers for commercial drug production. Under the Rasayana License Agreement, effective February 17, 2026, Rasayana is responsible for manufacturing SYN-020, including sourcing, receipt, storage, processing of raw materials, and all related manufacturing activities and costs. Manufacturing operations must comply with FDA and other regulatory requirements, including current Good Manufacturing Practice (cGMP) regulations. Drug manufacturers and subcontractors are required to register their facilities with the FDA and are subject to inspections. Non-compliance may result in regulatory actions. Both the company and its suppliers, including Rasayana, must adhere to these regulations for drug formulation, manufacturing, packaging, labeling, and storage.
Theriva Biologics Inc's Comment on Supply Chain
The company utilizes third-party manufacturers for commercial drug production. Under the Rasayana License Agreement, effective February 17, 2026, Rasayana is responsible for manufacturing SYN-020, including sourcing, receipt, storage, processing of raw materials, and all related manufacturing activities and costs. Manufacturing operations must comply with FDA and other regulatory requirements, including current Good Manufacturing Practice (cGMP) regulations. Drug manufacturers and subcontractors are required to register their facilities with the FDA and are subject to inspections. Non-compliance may result in regulatory actions. Both the company and its suppliers, including Rasayana, must adhere to these regulations for drug formulation, manufacturing, packaging, labeling, and storage.
Sources:
Theriva Biologics inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Theriva Biologics inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
